+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Immunity Booster Supplement Market by Form (Capsule, Liquid, Pill), Origin (Natural Supplements, Semi-Synthetic Supplements, Synthetic Supplements), Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5181420
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Immunity Booster Supplement Market size was estimated at USD 10.53 billion in 2023, USD 11.57 billion in 2024, and is expected to grow at a CAGR of 9.99% to reach USD 20.53 billion by 2030.

Immunity booster supplements are dietary products designed to fortify and enhance the body's immune system. These supplements contain vitamins, minerals, herbs, and other nutrients that support the body's natural defenses against pathogens, encompassing bacteria, viruses, and other harmful microorganisms. Common ingredients in these supplements include Vitamin C, Vitamin D, Zinc, Elderberry, and Echinacea. The formulation of these supplements aims to bolster the immune response, reduce the susceptibility to infections, and promote overall health and well-being.

Changing lifestyles and food habits, greater prevalence of immune-related illnesses, and inclination towards botanical ingredients and herbal supplements among the health-conscious crowd to boost immunity drive market growth. However, limited scientific evidence supporting the benefits and performance of immunity boosters and the high cost of availing raw materials hinder market adoption. Nevertheless, leveraging advancements in biotechnology and nanotechnology to create more efficient delivery systems represents a notable area for growth and differentiation.

Regional Insights

North America, particularly the United States and Canada, has experienced a substantial surge in the need for immunity booster supplements due to heightened health awareness, leading consumers to prioritize immunity as a preventative health measure. The market is characterized by various offerings, from traditional vitamins, such as Vitamin C and D, to more innovative products featuring herbal and plant-based ingredients. The presence of major health and wellness brands, along with a robust e-commerce sector, facilitates accessibility and awareness of these products.

In South America, the market for immunity booster supplements is growing steadily, driven by increasing health consciousness among the population and a growing middle class with more disposable income. Europe's immunity booster supplement market is mature and highly regulated, with a strong emphasis on scientifically backed products. The European Union's stringent health claims regulations ensure that only products meeting high safety and efficacy standards reach consumers. In the Middle East, countries, including the UAE and Saudi Arabia, are seeing rising interest in premium health and wellness products, including immunity supplements. Africa's market is evolving, with investments in healthcare infrastructure and growing consumer health consciousness contributing to a slow but positive growth trajectory. The APAC region is experiencing rapid development in the immunity booster supplements market due to a large and growing population, rising health awareness, and increasing disposable incomes, particularly in China, India, and Japan. China's market is poised for growth, driven by traditional Chinese medicine (TCM) and its integration with modern supplements. Japan highlights a preference for clinically proven products, with consumers showing keen interest in scientifically backed immunity boosters. India has seen a surge in demand for Ayurvedic immunity boosters, with customer purchasing behavior inclined towards traditional and natural supplements.

Market Trends by Segment

  • Origin: Burgeoning adoption of natural supplements aligns closely with their natural processes and absorption mechanisms
  • Distribution: Increasing inclination towards purchasing of immunity booster supplements from online distribution channels

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Disproquima Acquires Res Pharma to Advance “Life Science Industry Innovation”

Disproquima acquired Italian nutraceutical and ingredients powerhouse Res Pharma, heralding a significant expansion of its portfolio in the Life Sciences industry. Disproquima, known for its diversified distribution network and a wide array of premium raw materials, aims to synergize both companies' strengths and shared values through this acquisition.

Dr Reddy’s Enters Child Nutrition Space, Launches Immunity-Boosting Gummies

Dr. Reddy's Laboratories unveiled its latest product, immunity-enhancing gummies, aims to meet the increasing demand for nutritional supplements that support immune health, especially among children. This expansion underscores the company's commitment to enhancing global health through tailored nutritional solutions and opens new avenues for growth in the health supplement sector.

Well Traveled Launches Immune Support Supplement with BeniCaros

Well Traveled Health Inc. introduces its latest innovation, the Immune Activator dietary supplement, incorporating BeniCaros from NutriLeads BV. This formulation is designed to bolster travelers' immune systems, addressing the negative impacts of travel, such as dietary changes, disrupted sleep, and varying hydration levels. This distinctive supplement, leveraging robust scientific backing and high-quality branded components, aims to offer a superior option within a competitive market.

Key Company Profiles

The report delves into recent significant developments in the Immunity Booster Supplement Market, highlighting leading vendors and their innovative profiles. These include Amway Corp., Archer-Daniels-Midland Company, ARKOPHARMA Laboratories, Company Limited, Bayer AG, Church & Dwight Co. Inc., Country Farm, Cyanotech Co., E. I. duPont de Nemours and Company, FANCL Corporation, Glanbia PLC, GlaxoSmithKline PLC, Jamieson Laboratories Ltd., Nature's Bounty, Nature’s Way Brands, LLC, NOW Health Group, Inc., Nutraceutical International Corporation, Nutrivein, Oddity Healthcare Private Limited, Otsuka Holdings Co. Ltd, Pfizer Inc., Plant Power, Procter and Gamble Company, Purearth, Sambucol, and Sanofi S.A.

This research report offers invaluable insights into various crucial aspects of the Immunity Booster Supplement Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Changing Lifestyle and Food Habits Supplementing Demand for Dietary Supplements
5.1.1.2. Inclination towards Botanical Ingredients and Herbal Supplements among the Health-Conscious Crowd to Boost Immunity
5.1.1.3. Leading F&B Giants Venturing into the Functional Food Category
5.1.2. Restraints
5.1.2.1. Limited Scientific Evidences Supporting the Benefits and Performance of Immunity Boosters
5.1.2.2. Misleading Advertising and Promotion Strategies
5.1.3. Opportunities
5.1.3.1. Availability on Retail and E-Commerce Portals
5.1.3.2. Immunity Boosters Gaining Pace for Innovative Developments by Biotechnology and Pharmaceutical Sector
5.1.3.3. Focus on Product Traceability and Authenticity
5.1.4. Challenges
5.1.4.1. High Cost Associated with Availing Raw Material
5.2. Market Segmentation Analysis
5.2.1. Origin: Burgeoning adoption of natural supplements aligns closely with their natural processes and absorption mechanisms
5.2.2. Distribution: Increasing inclination towards purchasing of immunity booster supplements from online distribution channels
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Immunity Booster Supplement Market, by Form
6.1. Introduction
6.2. Capsule
6.3. Liquid
6.4. Pill
6.5. Powder
7. Immunity Booster Supplement Market, by Origin
7.1. Introduction
7.2. Natural Supplements
7.3. Semi-Synthetic Supplements
7.4. Synthetic Supplements
8. Immunity Booster Supplement Market, by Distribution
8.1. Introduction
8.2. Offline
8.3. Online
9. Americas Immunity Booster Supplement Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Immunity Booster Supplement Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Immunity Booster Supplement Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Disproquima Acquires Res Pharma to Advance “Life Science Industry Innovation”
12.3.2. Dr Reddy’s Enters Child Nutrition Space, Launches Immunity-Boosting Gummies
12.3.3. Well Traveled Launches Immune Support Supplement with BeniCaros
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. IMMUNITY BOOSTER SUPPLEMENT MARKET RESEARCH PROCESS
FIGURE 2. IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNITY BOOSTER SUPPLEMENT MARKET DYNAMICS
FIGURE 7. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2023 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. IMMUNITY BOOSTER SUPPLEMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. IMMUNITY BOOSTER SUPPLEMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. IMMUNITY BOOSTER SUPPLEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PILL, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PILL, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY POWDER, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY NATURAL SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY NATURAL SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SEMI-SYNTHETIC SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SEMI-SYNTHETIC SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SYNTHETIC SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SYNTHETIC SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 51. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 52. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 53. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 54. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 55. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 56. CANADA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 58. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 59. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 60. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 61. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 62. MEXICO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 85. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 86. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 87. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 88. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 89. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 90. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 91. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 92. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 93. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 94. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 95. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 96. INDIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 104. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 105. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 106. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 107. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 108. JAPAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 140. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 141. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 142. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 143. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 144. THAILAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 160. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 161. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 162. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 163. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 164. DENMARK IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 166. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 167. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 168. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 169. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 170. EGYPT IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 172. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 173. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 174. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 175. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 176. FINLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 178. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 179. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 180. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 181. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 182. FRANCE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 184. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 185. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 186. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 187. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 188. GERMANY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 195. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 196. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 197. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 198. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 199. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 200. ITALY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 214. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 215. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 216. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 217. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 218. NORWAY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 219. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 220. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 221. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 222. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 223. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 224. POLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 225. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 226. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 227. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 228. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 229. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 230. QATAR IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 250. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 251. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 252. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 253. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 254. SPAIN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 268. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 269. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 270. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 271. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 272. TURKEY IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
TABLE 285. IMMUNITY BOOSTER SUPPLEMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. IMMUNITY BOOSTER SUPPLEMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Amway Corp.
  • Archer-Daniels-Midland Company
  • ARKOPHARMA Laboratories, Company Limited
  • Bayer AG
  • Church & Dwight Co. Inc.
  • Country Farm
  • Cyanotech Co.
  • E. I. duPont de Nemours and Company
  • FANCL Corporation
  • Glanbia PLC
  • GlaxoSmithKline PLC
  • Jamieson Laboratories Ltd.
  • Nature's Bounty
  • Nature’s Way Brands, LLC
  • NOW Health Group, Inc.
  • Nutraceutical International Corporation
  • Nutrivein
  • Oddity Healthcare Private Limited
  • Otsuka Holdings Co. Ltd
  • Pfizer Inc.
  • Plant Power
  • Procter and Gamble Company
  • Purearth
  • Sambucol
  • Sanofi S.A.

Methodology

Loading
LOADING...

Table Information